ARS Pharmaceuticals Inc (SPRY) Price
SPRY Stock Price Chart
SPRY Financial
ARS Pharmaceuticals Inc
$8.88
0.33%
$0.03
$8.88
0%
$0
Income
Balance sheet
Cash flow
Annual
Quarterly
SPRY Income
Financials in millions USD. Fiscal year is February - January.
| Breakdown | TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 |
|---|---|---|---|---|---|---|
| Revenue | 112 | 89 | 0 | 1 | 0 | 0 |
| Revenue Growth (YoY) | -- | -- | -100% | -- | -- | -- |
| Cost of Revenue | 7 | 0 | -- | -- | -- | -- |
| Gross Profit | 105 | 88 | -- | -- | -- | -- |
| Selling, General & Admin | 150 | 71 | 47 | 18 | 28 | 8 |
| Research & Development | 14 | 19 | 20 | 18 | 61 | 24 |
| Operating Expenses | 164 | 91 | 67 | 36 | 89 | 32 |
| Other Non Operating Income (Expenses) | 11 | 11 | 13 | 1 | -- | -- |
| Pretax Income | -47 | 8 | -54 | -34 | -89 | -32 |
| Income Tax Expense | -- | 0 | -- | -- | -- | -- |
| Net Income | -48 | 7 | -54 | -34 | -89 | -32 |
| Net Income Growth | 9% | -112.99% | 59% | -62% | 178% | 39% |
| Shares Outstanding (Diluted) | 98.36 | 102.39 | 95.21 | 39.96 | 34.93 | 34.7 |
| Shares Change (YoY) | 2% | 8% | 138% | 14% | 1% | 5% |
| EPS (Diluted) | -0.48 | 0.07 | -0.57 | -0.87 | -2.56 | -0.95 |
| EPS Growth | 2% | -113.99% | -34% | -66% | 169% | 32% |
| Free Cash Flow | -53 | 12 | -59 | -40 | -68 | -32 |
| Free Cash Flow Per Share | -0.53 | 0.11 | -0.61 | -1 | -1.94 | -0.92 |
| Gross Margin | 93.75% | 98.87% | -- | -- | -- | -- |
| Operating Margin | -52.67% | -3.37% | 0% | -3,500% | 0% | 0% |
| Profit Margin | -42.85% | 7.86% | 0% | -3,400% | 0% | 0% |
| Free Cash Flow Margin | -47.32% | 13.48% | 0% | -4,000% | 0% | 0% |
| EBITDA | -59 | -3 | -67 | -35 | -89 | -32 |
| EBITDA Margin | -52.67% | -3.37% | 0% | -3,500% | 0% | 0% |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -59 | -3 | -67 | -35 | -89 | -32 |
| EBIT Margin | -52.67% | -3.37% | 0% | -3,500% | 0% | 0% |
| Effective Tax Rate | -- | 0% | -- | -- | -- | -- |
Follow-Up Questions
¿Cuáles son los estados financieros clave de ARS Pharmaceuticals Inc?
¿Cuáles son los ratios financieros clave para SPRY?
¿Cómo se desglosan los ingresos de ARS Pharmaceuticals Inc por segmento o geografía?
¿Es rentable ARS Pharmaceuticals Inc?
¿Tiene ARS Pharmaceuticals Inc alguna deuda?
¿Cuántas acciones en circulación tiene ARS Pharmaceuticals Inc?
Features
Trading Strategies
Resources
© 2025 Edgen Powered by
Ask AI About SPRY